![]() Emergency Use Authorization (EUA) Prescribing Information, which would allow for vaccine vials to be stored at these temperatures for a total of two weeks as an alternative or complement to storage in an ultra-low temperature freezer. The data have been submitted to the FDA to support a proposed update to the U.S. Food and Drug Administration (FDA) demonstrating the stability of their COVID-19 vaccine when stored at -25☌ to -15☌ (-13☏ to 5☏), temperatures more commonly found in pharmaceutical freezers and refrigerators. (NYSE: PFE) and BioNTech SE (Nasdaq: BNTX) today announced the submission of new data to the U.S. NEW YORK and MAINZ, GERMANY, FebruPfizer Inc. If approved, new storage option could offer pharmacies and vaccination centers greater flexibility in managing and maintaining vaccine distribution and supply.EUA label update would enable the vaccine to be stored at -25☌ to -15☌ (-13☏ to 5☏) for a total of two weeks Research and Business Development Partnerships. ![]() ![]() Unleashing the next wave of scientific innovations
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |